Literature DB >> 17825176

Inhibitary effects of antisense oligonucleotide specific to K-ras point mutation on the target gene expression in human pancreatic carcinoma cells.

Yong-xiang Wang1, Liang Gao, Zong-zheng Ji.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17825176

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN： 0366-6999            Impact factor:   2.628


× No keyword cloud information.
  4 in total

1.  Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides.

Authors:  Yong-Mei Shen; Xiao-Chun Yang; Chen Yang; Jun-Kang Shen
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

Review 2.  Gene therapy in pancreatic cancer.

Authors:  Si-Xue Liu; Zhong-Sheng Xia; Ying-Qiang Zhong
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

3.  Apoptosis of human pancreatic carcinoma PC-2 cells by an antisense oligonucleotide specific to point mutated K-ras.

Authors:  Wang Yongxiang; Gao Liang; Shao Qinshu
Journal:  Pathol Oncol Res       Date:  2013-07-05       Impact factor: 3.201

4.  Mutation analysis of the EGFR pathway genes, EGFR, RAS, PIK3CA, BRAF, and AKT1, in salivary gland adenoid cystic carcinoma.

Authors:  Kosuke Saida; Takayuki Murase; Mayuko Ito; Kana Fujii; Hisashi Takino; Ayako Masaki; Daisuke Kawakita; Kei Ijichi; Yuichiro Tada; Kimihide Kusafuka; Yoshiyuki Iida; Tetsuro Onitsuka; Yasushi Yatabe; Nobuhiro Hanai; Yasuhisa Hasegawa; Hitomi Shinomiya; Ken-Ichi Nibu; Kazuo Shimozato; Hiroshi Inagaki
Journal:  Oncotarget       Date:  2018-03-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.